FDA health advisers back first-in-class cholesterol drug

... risk of heart disease, the leading cause of death in the U.S. Paris-based Sanofi and Regeneron, which is based in Tarrytown, New York, have suggested marketing their drug to a large group of patients, including those who are at high-risk for heart ...
http://ift.tt/1S4Oai8